NF-κB inhibition by an adenovirus expressed aptamer sensitizes TNFα-induced apoptosis

Biochemical and Biophysical Research Communications

Volumn 359, Issue 3, 2007, Pages 475-480

  Mi, Jing ^a   Zhang, Xiuwu ^a   Liu, Yingmiao ^a   Reddy, Srinevas K ^a   Rabbani, Zahid N ^a   Sullenger, Bruce A ^a   Clary, Bryan M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Aptamer; HIF 1 ; NF B; TNF

Indexed keywords

ADENOVIRUS VECTOR; APTAMER; DNA DIRECTED RNA POLYMERASE III; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; PROTEIN P50; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADENOVIRUS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; SENSITIZATION; TUMOR CELL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY;

ADENOVIRIDAE;

ADENOVIRIDAE; APOPTOSIS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250207720     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.05.125     Document Type: Article

References (17)

1. Nakanishi C., and Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat. Rev. Cancer 5 (2005) 297-309
2. Papa S., Zazzeroni F., Pham C.G., Bubici C., and Franzoso G. Linking JNK signaling to NF-kappaB: a key to survival. J. Cell Sci. 117 (2004) 5197-5208
3. Winn R.K., and Harlan J.M. The role of endothelial cell apoptosis in inflammatory and immune diseases. J. Thromb. Haemost. 3 (2005) 1815-1824
4. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
5. Basseres D.S., and Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25 (2006) 6817-6830
6. Mi J., Zhang X., Rabbani Z.N., Liu Y., Su Z., Vujaskovic Z., Kontos C.D., Sullenger B.A., and Clary B.M. H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res. 34 (2006) 3577-3584
7. Zhang D.H., Marconi A., Xu L.M., Yang C.X., Sun G.W., Feng X.L., Ling C.Q., Qin W.Z., Uzan G., and d'Alessio P. Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. J. Leukoc. Biol. 80 (2006) 309-319
8. Holschermann H., Schuster D., Parviz B., Haberbosch W., Tillmanns H., and Muth H. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 185 (2006) 240-245
9. Arenzana-Seisdedos F., Turpin P., Rodriguez M., Thomas D., Hay R.T., Virelizier J.L., and Dargemont C. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J. Cell Sci. 110 (1997) 369-378
10. Scatena M., Almeida M., Chaisson M., Fausto N., Nicosia R., and Giachelli C. NF-κB mediates αvβ3 integrin-induced endothelial cell survival. J. Cell Biol. 141 (2007) 1083-1093
11. Ho F.M., Lin W.W., Chen B.C., Chao C.M., Yang C.T., Lin L.Y., Lai C.C., Liu S.H., and Liau C.S. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell. Signal. 18 (2006) 391-399
12. Yang P., Mckay B.S., Allen J.B., and Jaffe G.J. Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2438-2446
13. Cusack J.C. Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib. Cancer Treat. Rev. 29 Suppl. 1 (2003) 21-31
14. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
15. Que-Gewirth N.S., and Sullenger B.A. Gene therapy progress and prospects: RNA aptamers. Gene Ther. 14 (2007) 283-291
16. Billich A., Bornancin F., Mechtcheriakova D., Natt F., Huesken D., and Baumruker T. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell. Signal. 17 (2005) 1203-1217
17. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. (Lond.) 108 (2005) 205-213